ここから本文です

To Our Shareholders

Our growth and progress is a never-ending process.

Kunihisa Furukawa Chairman
Kunihisa Furukawa
Chairman
Futoshi Ohashi President
Futoshi Ohashi
President


We wish to express our gratitude to all our shareholders for your continuing support.

We would like to express our deepest sympathies to all people affected by COVID-19. Although the epidemic of the infectious disease has subsided, we are deeply grateful to the medical professionals who are involved in daily treatment to support our lives and economic activities in the society.

The Group successfully achieved the targets of the medium-term management plan "SHIP VISION 2020" in the previous fiscal year (ending March 2021), and is accelerating efforts toward the next long-term target of "consolidated sales of 1 trillion yen." In the medical industry to which the Group belongs, by the trigger of measures against the new COVID-19 infection, the importance of regional medical care concepts, cooperation between medical care and nursing care, and productivity improvement using ICT/automated equipment, which have been recognized as issues, has become clearer. In this turbulent environment, the Group will continue to capture the "trend", always provide advanced value as an innovator in the medical industry and develop various strategies with entire group.

The new organization system, which was established in April this year to further strengthen the management base, started its operation in October. Under this new system, directors in charge are appointed for each business division and corporate management department to strengthen cooperation and governance between departments. To achieve the long-term goal of group sales of 1 trillion yen, we will review and strengthen the organization, maximize group synergies, and further progress toward future development.

Under the group philosophy of SHIP (Sincere, Humanity, Innovation, PartnerSHIP), the Group will strive to further improve corporate value as a corporate group that have both "morality and self-interest" based on the premise of partnership with all stakeholders. While fulfilling the group mission of "Create environment for medical professionals", we will contribute to society through various know-how cultivated so far to realize "well-being" for all people.

We appreciate all of you for your continued support and encouragement.

Aiming for consolidated net sales of 1 trillion yen as long-term target, we will respond to drastic changes in the business environment and promote initiatives with short, medium, and long term perspectives.

Financial Results

Profit significantly exceeds planned value due to recovery from COVID-19 pandemic.

Healthcare industry in which the Group operates, while the medical care system temporarily became overwhelmed than ever due to the fifth wave of the spread of COVID-19 in Japan, the industry trend has recovered compared to the same period of last year due to the rapid decrease in the number of newly infected people with the progress of vaccination.
In Total Pack Produce business, the sales of infection control equipment such as simplified negative pressure devices were favorable, however, the business performance was weak overall because the plan of completion of many projects for hospitals were placed in the second half.

In Medical Supply business, the business performance was firm compared to the same period of last year due to the recovery trend of the sales of medical consumables. At the same time, an efficient management and operation system has been prepared with the start of full-scale operation of "Osaka Solution Center". In addition, in Lifecare business, we could maintain a high occupancy rate, and in the Dispensing Pharmacy business, we have accumulated stable results through M&A of small stores. As a result, sales were 234.6 billion yen, exceeding the planned value. In terms of profitability, operating income increased 16.8% from the planned value and net income attributable to owners of the parent increased 8.4% from the planned value.

業績結果

(millions yen)

Initial forecast
(announced May 11, 2021)
2021/9 Actual
(Q2 of FY2021)
Rate of change
Net sales 225,000 234,663 4.3%
Operating income 6,500 7,593 16.8%
Ordinary income 6,500 7,378 13.5%
Profit attributable to
owners of parent
3,800 4,118 8.4%

Key point to achieve long-term goals

Utilize the comprehensive strength of the group and promote collaboration between the segments

Since its founding, the Group has welcomed many group companies, and as of the end of September 2021, we have become a corporate group consisting of 56 companies. While valuing the spirit of autonomy and independence, the Group has expanded its business by cooperation within the segments. Under such circumstances, we are accelerating efforts to maximize the know-how and strengths of each group company toward the further development of the Group and the next corporate stage.
The Group's greatest strength is its total ability of proposal, which is realized by companies that can meet various needs in the field of healthcare exchanging information and cooperating with each other across the boundaries of each group company and segment. As each company continues to grasp the “trendy” needs, the Group has accumulated a huge amount of knowledge and know-how, and by making the best use of them within the Group, we can provide better services to society. We will grow into an unrivaled corporate group with the comprehensive know-how. In addition, in the "KKB business (Kankyo (environment)・Kansen (infection control)・Bosai (disaster prevention)" planned against the backdrop of the spread of COVID-19, we will proactively provide services that help solve social issues, such as starting the manufacture and sale of made-in-Japan high-quality medical masks. We are promoting the diversification of our business by making the best use of our experience.
The Group will achieve its long-term goals through various growth strategies that go beyond the conventional framework.

Progress of major initiatives

Past efforts flourish in each segment

In the current fiscal year, we are entering a new phase, with the various measures we have been working on achieving results. The "Osaka Solution Center," which will be the core of the Medical Supply business in the future, started full-scale operation in June 2021, and the number of contracted medical institutions is gradually expanding mainly in the Kansai region. Also, in the hospital in Bangladesh, which is the first overseas hospital operation of our Group, we are contributing to the improvement of medical infrastructure and access in the country by gradually starting general medical care while achieving high treatment results in the treatment of COVID-19. In the KKB (Kankyo (environment)・Kansen (infection control)・Bosai (disaster prevention) business, it is a challenge from the conventional BtoB business to the BtoC model, and also, as an area that is essential for the group's contribution to solving social issues and our growth in the long-term future, we are planning measures that utilize the group's collective strength with the concept of “living better (well-being)”. The Group will aim for further growth under the new organization toward the next corporate stage.

Initiatives of each business segment

TPP We will respond to various market needs such as infectious control measures and comprehensive regional medical care systems, and expand the business coverage area.
MSP Promote advanced medical material logistics "Smart Medical Solutions" centered on the Osaka Solution Center and promote client development.
LC Continuing to keep a high occupancy rate, and we will do the effort to control the infection and secure the safety and security of residents.
PH At the same time as building a new service model that does not rely on public insurance income, we will strengthen profitability through M&A etc..
HS Strengthen the operation of services that have already been launched and develop new services.